Pharmafile Logo
Pharmafocus logo
Advanced Search

Positive Initial Data Analysis in POLB 001 LPS Challenge Trial

January 9, 2023
Business Services

9 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …

News
Press release

Novo Holdings invests in proteomics technology company, Evosep

January 9, 2023
Business Services

The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep’s …

News
Press release

FDA approves Eisai-Biogen’s lecanemab for Alzheimer’s disease

January 9, 2023
Research and Development

The FDA has approved Eisai and Biogen’s experimental antibody treatment lecanemab (also known as Leqembi) for the treatment of mild …

News

AstraZeneca set to buy CinCor for $1.8bn

January 9, 2023
Sales and Marketing

AstraZeneca has announced that it is set to acquire the clinical-stage biopharmaceutical company CinCor in a deal worth up to …

News

$22m raised by PBS Biotech to expand single-use manufacturing products and services for cell therapy clients

January 9, 2023
Manufacturing and Production

PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider, has worked together with Avego Management and BroadOak …

News

Sarepta Therapeutics and Catalent sign manufacturing deal for DMD gene therapy approval

January 9, 2023
Manufacturing and Production

Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. …

News

James Noble

January 6, 2023
Business Services

St Andrews, UK – 6 January 2023 – Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal …

Appointment

Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration

January 6, 2023
Business Services

Strasbourg, France, January 6, 2023, 7:30 a.m.

News
Press release

Sanofi plans eco-friendly additions to Brisbane manufacturing campus

January 6, 2023
Manufacturing and Production

Sanofi is aiming to expand its eco-friendly and renewable energy ecosystem with plans to install solar panels on the carpark, …

News

Moderna agrees first acquisition for $85m

January 6, 2023
Sales and Marketing

After a pivotal few years, Moderna has agreed its first acquisition, worth $85m, which will allow the company access to …

News

BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies

January 6, 2023
Medical Communications

German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …

News

Withings announces hands-free connected in-home urine lab

January 6, 2023
Medical Communications

Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise …

News

Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs

January 5, 2023
Medical Communications

AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for …

News
Press release

Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer

January 5, 2023
Business Services

BASEL, Switzerland – 5th January 2023 – Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced …

News
Press release

Lidia Oostvogels

January 5, 2023
Business Services

MinervaX appoints Lidia Oostvogels as Chief Medical Officer and provides clinical and regulatory update on its novel GBS vaccine

Appointment

iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program

January 5, 2023
Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 5 January – iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that …

News
Press release

Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform

January 5, 2023
Business Services

Copenhagen, Denmark, January 5, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

News
Press release

Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders

January 5, 2023
Business Services

Tokyo, Japan and Cambridge, UK, 5 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

FDA accepts application for nirsevimab as first protective option for RSV in infants

January 5, 2023
Medical Communications

The FDA has accepted an application for nirsevimab as the first protective option to combat respiratory syncytial virus (RSV) disease …

News

Island Pharmaceuticals to begin phase 2 trial for dengue prevention and treatment drug

January 5, 2023
Research and Development

It is possible that Island Pharmaceuticals could begin its phase 2a PEACH clinical trial as soon as January 2023. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025